Dr. David Samadi, prostate cancer surgeon, shares news of a new FDA-approved weight loss drug, Qsymia. This approval comes on the heels of Belviq, the first weight loss drug approved in the past 13 years. Dr. Samadi touches on the pros and cons of prescription weight loss medication. Qsymia is indicated for those who are obese or those who are overweight and have other medical conditions such as high blood pressure or heart disease.
www.smart-surgery.com